Sasaki Awarded R21 Grant to Study Targeted Treatments for Brain Cancer
September 1, 2016
Atsuo Sasaki, PhD, has been awarded an NIH grant to study a targeted and safe treatment for glioblastoma multiforme, the most aggressive form of brain cancer.